Cargando…

Development of a high-precision bladder hyperthermic intracavitary chemotherapy device for bladder cancer and pharmacokinetic study

BACKGROUND: Bladder hyperthermic intracavitary chemotherapy (HIVEC) has good effectiveness for bladder cancer, but conventional HIVEC systems lack precision and convenient application. To test the safety of a new HIVEC device (BR-TRG-II-type) in pigs and to perform a preliminary clinical trial in pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ba, Mingchen, Cui, Shuzhong, Long, Hui, Gong, Yuanfeng, Wu, Yinbing, Lin, Kunpeng, Tu, Yinuo, Zhang, Bahuo, Wu, Wanbo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892136/ https://www.ncbi.nlm.nih.gov/pubmed/31795980 http://dx.doi.org/10.1186/s12894-019-0543-8

Ejemplares similares

Safety and Effectiveness of High-Precision Hyperthermic Intraperitoneal Perfusion Chemotherapy in Peritoneal Carcinomatosis: A Real-World Study
por: Ba, Mingchen, et al.
Publicado: (2021)

Efficacy and safety of ultrasound-guided continuous hyperthermic intraperitoneal perfusion chemotherapy for the treatment of malignant ascites: a midterm study of 36 patients
por: Wu, Yinbing, et al.
Publicado: (2016)

Cytoreductive surgery and HIPEC for malignant ascites from colorectal cancer - a randomized study
por: Ba, Mingchen, et al.
Publicado: (2020)

The rectum and bladder doses in intracavitary brachytherapy for cervical cancer
por: Sharma, Brahmacharimayum Arunkumar, et al.
Publicado: (2011)

Hyperthermic Intravesical Chemotherapy for BCG Unresponsive Non-Muscle Invasive Bladder Cancer Patients
por: de Jong, Joep J., et al.
Publicado: (2018)

A scalable hyperthermic intravesical chemotherapy (HIVEC) setup for rat models of bladder cancer
por: Van Hattum, J. W., et al.
Publicado: (2022)

A multi-institutional retrospective study of hyperthermic plus intravesical chemotherapy versus intravesical chemotherapy treatment alone in intermediate and high risk nonmuscle-invasive bladder cancer
por: Ruan, Qiang, et al.
Publicado: (2021)

Pharmacokinetics of Hyperthermic Intrathoracic Chemotherapy following Pleurectomy and Decortication
por: Sugarbaker, Paul H., et al.
Publicado: (2012)

Adjuvant Hyperthermic Intravesical Chemotherapy in Intermediate- and High-Risk Non-muscle Invasive Bladder Cancer
por: Magalhães, Joana C, et al.
Publicado: (2023)

Hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis: A multicenter propensity score-matched cohort study
por: Lei, Ziying, et al.
Publicado: (2020)

A study on the variation of bladder and rectal doses with respiration in intracavitary brachytherapy for cervix cancer
por: Prabhakar, Ramachandran, et al.
Publicado: (2010)

Hyperthermic intravesical chemotherapy with mitomycin‐C for the treatment of high‐risk non‐muscle‐invasive bladder cancer patients
por: Conroy, Samantha, et al.
Publicado: (2022)

Noncoding RNAs and hyperthermic intraperitoneal chemotherapy in advanced gastric cancer
por: Zeng, Lisi, et al.
Publicado: (2022)

Hyperthermic intracavitary nanoaerosol therapy (HINAT) as an improved approach for pressurised intraperitoneal aerosol chemotherapy (PIPAC): Technical description, experimental validation and first proof of concept
por: Göhler, Daniel, et al.
Publicado: (2017)

A comparison of organs at risk doses in GYN intracavitary brachytherapy for different tandem lengths and bladder volumes
por: Siavashpour, Zahra, et al.
Publicado: (2016)

Tumor Mutational Burden Associated With Response to Hyperthermic Intraperitoneal Chemotherapy
por: Zeng, Lisi, et al.
Publicado: (2022)

Long-Term Experience with Hyperthermic Chemotherapy (HIVEC) Using Mitomycin-C in Patients with Non-Muscle Invasive Bladder Cancer in Spain
por: Plata, Ana, et al.
Publicado: (2021)

Optimal bladder filling during high-dose-rate intracavitary brachytherapy for cervical cancer: a dosimetric study
por: Mahantshetty, Umesh, et al.
Publicado: (2017)

Vaginal Fistulas of the Bladder and Small Bowel After Two-Dimensional Intracavitary Brachytherapy in a Patient With Cervical Cancer
por: Yamada, Yuki, et al.
Publicado: (2020)

A precise temperature control during hyperthermic intraperitoneal chemotherapy promises an early return of bowel function
por: Ye, Jinning, et al.
Publicado: (2020)

Hyperthermic intraperitoneal chemotherapy in advanced ovarian cancer
por: Wu, Tao, et al.
Publicado: (2018)

Hyperthermic Intraoperative Thoracoabdominal Chemotherapy
por: Sugarbaker, Paul H., et al.
Publicado: (2012)

Hyperthermic intrapleural chemotherapy: an update
por: Campany, Megan E., et al.
Publicado: (2023)

Cytoreductive onco-surgery with combined hyperthermic intraperitoneal chemotherapy and hyperthermic intrathoracic chemotherapy: Perioperative challenges
por: Dattatri, Rohini, et al.
Publicado: (2019)

Different effects of bladder distention on point A-based and 3D-conformal intracavitary brachytherapy planning for cervical cancer
por: Ju, Sang Gyu, et al.
Publicado: (2013)

Body Surface Area Predicts Plasma Oxaliplatin and Pharmacokinetic Advantage in Hyperthermic Intraoperative Intraperitoneal Chemotherapy
por: Leinwand, Joshua C., et al.
Publicado: (2013)

Pharmacokinetics and toxicity of carboplatin used for hyperthermic intraperitoneal chemotherapy (HIPEC) in treatment of epithelial ovarian cancer
por: Mikkelsen, Mette Schou, et al.
Publicado: (2020)

A Dose-Finding Trial for Hyperthermic Intraperitoneal Cisplatin in Gynecological Cancer Patients Receiving Hyperthermic Intraperitoneal Chemotherapy
por: Chan, Chui-ying, et al.
Publicado: (2021)

Intracavitary nodule
por: Marchiori, Edson, et al.
Publicado: (2016)

Intracavitary prophylactic treatment with interferon alpha 2b of patients with superficial bladder cancer is associated with a systemic T-cell activation.
por: Molto, L., et al.
Publicado: (1994)

Dosimetric evaluation of rectum and bladder using image-based CT planning and orthogonal radiographs with ICRU 38 recommendations in intracavitary brachytherapy
por: Jamema, Swamidas V., et al.
Publicado: (2008)

Anesthetic implications in hyperthermic intraperitoneal chemotherapy
por: Gupta, Nishkarsh, et al.
Publicado: (2019)

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
por: Riggs, McKayla J., et al.
Publicado: (2020)

Comparison of open and closed hyperthermic intraperitoneal chemotherapy: Results from the United States hyperthermic intraperitoneal chemotherapy collaborative
por: Leiting, Jennifer L, et al.
Publicado: (2020)

Case report: Gemcitabine intravesical hyperthermic infusion combined with tislelizumab in muscle invasive bladder urothelium carcinoma
por: Du, Zheng, et al.
Publicado: (2022)

Systematic review and meta-analysis on laparoscopic cystectomy in bladder cancer
por: Zhu, Jialiang, et al.
Publicado: (2022)

Effect of bladder distension on dosimetry of organs at risk in computer tomography based planning of high-dose-rate intracavitary brachytherapy for cervical cancer
por: Patra, Niladri B., et al.
Publicado: (2013)

Dosimetric analysis of the effects of the bladder volume on organs at risk (OAR) in high-dose-rate intracavitary brachytherapy in carcinoma cervix – an institutional study
por: Sharma, Ashutosh Das, et al.
Publicado: (2018)

Rectal and Bladder Dose Measurements in the Intracavitary Applications of Cervical Cancer Treatment with HDR Afterloading System: Comparison of TPS Data with MOSFET Detector
por: N., Singh, et al.
Publicado: (2020)

Multimodal Treatment Including Intracavitary Chemotherapy for Recurrent Pediatric Pleuropulmonary Blastoma
por: Habti, Merieme, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_i0v2pn2mdrgepsuhhcku2n4q6c